NSE · AI Signal & Stock Analysis · Bearish
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for DIVISLAB is Bearish ↓ (strong move); technical trend raise-2026-07-02; trading at ₹9,315.00 (+2.36% today); neutral (RSI 69).
Data as of Sep 28 2026, 6:47 PM. Informational analytics only — not investment advice.
| AI signal | Bearish ↓ · Strong move |
|---|---|
| Technical trend | RAISE-2026-07-02 |
| Price | ₹9,315.00 |
| Change today | +2.36% |
| RSI (14) | 69.20 |
| Relative volume | 1.19 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹2.54 Lakh Cr |
| P/E | 86.33 |
| Cap category | Mega Cap |
| 52-week high | -1.6% away |
| 52-week low | +63.7% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for DIVISLAB (Divi's Laboratories Limited) is Bearish with a strong move, and its technical trend is raise-2026-07-02. The composite score and full factor breakdown are available to signed-in members.
DIVISLAB's RSI is neutral (RSI 69). A reading above 70 is typically overbought and below 30 oversold.
DIVISLAB is trading about 2% below its 52-week high and 64% above its 52-week low as of Sep 28 2026, 6:47 PM.
DIVISLAB's market capitalisation is ₹2.54 Lakh Cr as of Sep 28 2026, 6:47 PM.
DIVISLAB is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for DIVISLAB — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AJANTPHARM · AKUMS · ALIVUS · ALKEM
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Sep 28 2026, 6:47 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.